FeesSafety
Pluang+

Jasper Therapeutics reports Q3 2026 results, advances kidney disease drug trials, and completes Kira acquisition.

Company Fundamentals
16 Nov 2026, 15:00 WIB
GlobeNewsWire
View Source
Bullish
Jasper Therapeutics reports Q3 2026 results, advances kidney disease drug trials, and completes Kira acquisition.

Jasper Therapeutics announced its Q3 2026 financial results, highlighting progress in its Phase 2 renal basket study for vensobafusp alfa targeting kidney diseases like IgA nephropathy, IC-MPGN, and FSGS. The company completed enrollment in the first cohort and plans to report interim data by late 2026. Jasper also completed the acquisition of Kira Pharmaceuticals, boosting its pipeline and secured $132 million in funding. Financially, Jasper reported a net loss of $144.5 million for Q3, with cash reserves of $135.3 million as of September 30, 2026. The company is advancing multiple therapies for immune-mediated diseases and expects further clinical updates in 2027.

Jasper Therapeutics' recent Q3 2026 report highlights a net loss of $144.5 million and cash reserves of $135.3 million as of September 30, 2026. For readers following the health sector, here is Pluang's market snapshot as of Nov 16, 2026 19:13 WIB: out of 150 priced US health stocks, 67 rose and 61 fell. Notable movers include Centene Corp (CNC) at USD 73.80 with a 3.55% increase, Brookdale Senior Living Inc. (BKD) at USD 8.85 down 3.49%, and Tango Therapeutics Inc. (TNGX) at USD 24.64 down 3.37%.

More News

Nike faces scrutiny over cost-cutting ahead of first investor day since 2017

Nike faces scrutiny over cost-cutting ahead of first investor day since 2017

Nike is under pressure to clarify its cost-cutting plans as it prepares for its first investor day since 2017, scheduled for November 16–17. Despite efforts led by CEO Elliott Hill to turn the company around, management expects revenue to decline by ...

Market News
Bearish
55 minutes ago
Jackery and Every Electric launch North America's first plug-in virtual power plant for renters in NYC.

Jackery and Every Electric launch North America's first plug-in virtual power plant for renters in NYC.

Jackery and Every Electric have partnered to create North America's first plug-and-play virtual power plant (VPP) for renters and apartment residents, starting in New York City. This innovative system uses portable power stations plugged into standar...

Market News
Bullish
1 hour ago
P-1 AI names retired Brig. Gen. Matt Isler GM for Aerospace and Defense to boost AI engineering efforts.

P-1 AI names retired Brig. Gen. Matt Isler GM for Aerospace and Defense to boost AI engineering efforts.

P-1 AI has appointed retired Brigadier General Matt Isler as General Manager for its Aerospace and Defense division. Isler brings nearly 30 years of military and industry experience, including leadership roles at Northrop Grumman and startup DEFCON A...

Market News
Bullish
1 hour ago
Saputo renews share buyback plan to repurchase up to 10% of public shares by Nov 2027

Saputo renews share buyback plan to repurchase up to 10% of public shares by Nov 2027

Saputo Inc. has renewed its Normal Course Issuer Bid (NCIB), allowing it to repurchase up to 22.5 million common shares, representing 10% of its public float, from November 19, 2026, to November 18, 2027. This move reflects Saputo's strategy to retur...

Company Fundamentals
Bullish
2 hours ago
GitGuardian expands program to alert companies of leaked credentials, boosting enterprise cybersecurity worldwide.

GitGuardian expands program to alert companies of leaked credentials, boosting enterprise cybersecurity worldwide.

GitGuardian has launched the Enterprise Good Samaritan Program to identify and notify companies about high-impact leaked credentials that could expose their systems to attackers. Using AI and expert analysis, the program traces leaks to affected orga...

Market News
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App